SCHEMBL16257510

SCHEMBL16257510

Cc1c(Cl)nc(C(F)(F)F)nc1Nc1ccc(Cl)c(Cl)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAPGEF4 Q8WZA2 2/20 0.41
SMN1; SMN2 Q16637 3/20 0.40
TP53 P04637 2/20 0.40
MAPT P10636 1/20 0.40
CCR2 P41597 1/20 0.40
CCR5 P51681 1/20 0.40
KDM4E B2RXH2 2/20 0.40
ALDH1A1 P00352 1/20 0.40
CDK2 P24941 1/20 0.39
NPY5R Q15761 1/20 0.39
POLA1 P09884 1/20 0.38
TRPV1 Q8NER1 1/20 0.37
BRAF P15056 1/20 0.37
DHODH Q02127 1/20 0.36
STK17A Q9UEE5 1/20 0.36
GRM4 Q14833 1/20 0.36
NPC1 O15118 1/20 0.36
ALOX15 P16050 1/20 0.36
TSHR P16473 1/20 0.36
RAB9A P51151 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16257566 0.82 MEN1 (0.42) SMN1; SMN2TP53MAPTCCR2CCR5
SCHEMBL15083664 0.78 CCR2 (0.43) RAPGEF4SMN1; SMN2TP53MAPTCCR2
SCHEMBL15033797 0.76 MAPT (0.49) RAPGEF4SMN1; SMN2TP53MAPTNPY5R
SCHEMBL2743307 0.69 PDE10A (0.39) KDM4EALDH1A1
SCHEMBL20539053 0.67 DHODH (0.68) DHODHALOX15HSD17B10
SCHEMBL15119854 0.67 NPC1 (0.41) SMN1; SMN2MAPTKDM4EALDH1A1NPC1
SCHEMBL10956452 0.66 ERBB2 (0.55) RAPGEF4SMN1; SMN2TP53GRM4NPC1
SCHEMBL15033751 0.66 KMO (0.45) RAPGEF4SMN1; SMN2MAPTKDM4ENPY5R
SCHEMBL24754871 0.65 MAPT (0.49) SMN1; SMN2TP53MAPTCCR2CCR5
SCHEMBL15033703 0.65 MAPT (0.63) RAPGEF4SMN1; SMN2TP53MAPTCCR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8946218-B2 CCR2 receptor antagonists, method for producing the same, and use thereof as medicaments BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2015-02-03 US disclosed
EP-2569295-B1 NEW CCR2 RECEPTOR ANTAGONISTS, METHOD FOR PRODUCING THE SAME, AND USE THEREOF AS MEDICAMENTS BOEHRINGER INGELHEIM INT (DE) 2014-11-19 EP disclosed